Kris MG - Search Results

1

Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with Lung Adenocarcinoma with EGFR Exon 20 Insertions.

Choudhury NJ, Schoenfeld AJ, Flynn J, Falcon CJ, Rizvi H, Rudin CM, Kris MG, Arcila ME, Heller G, Yu HA, Ladanyi M, Riely GJ. Choudhury NJ, et al. Among authors: kris mg. Clin Cancer Res. 2021 May 15;27(10):2920-2927. doi: 10.1158/1078-0432.CCR-20-4650. Epub 2021 Mar 8. Clin Cancer Res. 2021. PMID: 33685865 Free PMC article.

2

Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer.

Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M, Dmitrovsky E. Rusch V, et al. Cancer Res. 1995 Nov 1;55(21):5038-42. Cancer Res. 1995. PMID: 7585548

3

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: kris mg. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

4

Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.

Pisters KM, Kris MG, Gralla RJ, Zaman MB, Heelan RT, Martini N. Pisters KM, et al. Among authors: kris mg. J Clin Oncol. 1993 Sep;11(9):1757-62. doi: 10.1200/JCO.1993.11.9.1757. J Clin Oncol. 1993. PMID: 8394881

5

Metabolic phenotypes of retinoic acid and the risk of lung cancer.

Rigas JR, Miller VA, Zhang ZF, Klimstra DS, Tong WP, Kris MG, Warrell RP Jr. Rigas JR, et al. Among authors: kris mg. Cancer Res. 1996 Jun 15;56(12):2692-6. Cancer Res. 1996. PMID: 8665495

6

Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.

Grant SC, Kris MG, Houghton AN, Chapman PB. Grant SC, et al. Among authors: kris mg. Clin Cancer Res. 1999 Jun;5(6):1319-23. Clin Cancer Res. 1999. PMID: 10389914 Clinical Trial.

7

Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.

Dickler MN, Ragupathi G, Liu NX, Musselli C, Martino DJ, Miller VA, Kris MG, Brezicka FT, Livingston PO, Grant SC. Dickler MN, et al. Among authors: kris mg. Clin Cancer Res. 1999 Oct;5(10):2773-9. Clin Cancer Res. 1999. PMID: 10537341

8

The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.

Parekh K, Rusch V, Kris M. Parekh K, et al. Cancer. 1999 Nov 1;86(9):1720-3. Cancer. 1999. PMID: 10547544

9

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.

Krug LM, Ng KK, Kris MG, Miller VA, Tong W, Heelan RT, Leon L, Leung D, Kelly J, Grant SC, Sirotnak FM. Krug LM, et al. Among authors: kris mg. Clin Cancer Res. 2000 Sep;6(9):3493-8. Clin Cancer Res. 2000. PMID: 10999734 Clinical Trial.

10

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.

Sirotnak FM, Zakowski MF, Miller VA, Scher HI, Kris MG. Sirotnak FM, et al. Among authors: kris mg. Clin Cancer Res. 2000 Dec;6(12):4885-92. Clin Cancer Res. 2000. PMID: 11156248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters